瓣膜性心脏病中的性别相关因素
该综述系统梳理了瓣膜性心脏病全程中的性别差异,涵盖病理生理、疾病进展、代偿与合并症、严重程度与血流动力学评估、干预时机及手术风险与结局。主动脉瓣的性别差异在病理改变和容量/压力负荷反应方面理解最深,但其他瓣膜病的研究多集中于患病率、表现及手术或经导管治疗结局。明确性别特异性反应有望改善疾病识别、治疗策略和预后。
要点
- 瓣膜性心脏病从病理生理到干预结局全程存在性别差异。
- 主动脉瓣性别差异理解较深,但整体认知仍有较大空白。
- 明确性别特异性反应可改善识别、治疗策略与预后。
核心结论
- 瓣膜性心脏病全程存在性别差异,明确性别特异性反应可能改善疾病识别、治疗策略和结局。
研究设计与样本
- 本文为JACC焦点研讨会综述,系统梳理瓣膜性心脏病中性别相关因素的现有证据。
主要发现
- 性别差异贯穿病理生理、疾病进展、代偿与合并症、严重程度与血流动力学评估、干预时机及手术风险与结局。
- 主动脉瓣在病理改变及对容量和压力负荷的反应方面性别差异理解较深,但仍存在较大认知空白。
- 其他瓣膜病研究多关注患病率、表现及外科或经导管治疗结局的性别差异。
临床怎么用
- 临床评估瓣膜性心脏病时应考虑性别相关差异,以优化疾病识别和治疗策略。
局限性
- 主动脉瓣以外的瓣膜病性别差异证据多限于患病率、表现和治疗结局,整体认知仍存在较大空白。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Numerous sex-based differences are observed across the spectrum of valvular heart disease, starting with pathophysiology and progression of disease, moving on to compensation and comorbidities (both cardiovascular such as coronary artery disease and noncardiovascular such as frailty), assessment of severity and hemodynamics including timing of intervention, and procedural risks/benefits and outcomes. The aortic valve is perhaps best understood with sex differences in both pathologic changes and response to volume and pressure overload, yet large gaps in our understanding still exist. Studies of other valve diseases have focused on differences in prevalence, presentation, and outcomes for surgical or transcatheter therapies. Defining sex-specific responses to valvular heart disease may improve disease recognition, define treatment strategies, and improve outcomes.
引用
- Hahn RT, Clavel MA, Mascherbauer J, et al. Sex-Related Factors in Valvular Heart Disease: JACC Focus Seminar 5/7. J Am Coll Cardiol. 2022. PMID: 35422247. doi:10.1016/j.jacc.2021.08.081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。